South Dakota Investment Council decreased its holdings in Kenvue Inc. (NYSE:KVUE – Free Report) by 9.3% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 386,353 shares of the company’s stock after selling 39,600 shares during the quarter. South Dakota Investment Council’s holdings in Kenvue were worth $6,823,000 at the end of the most recent quarter.
A number of other hedge funds have also added to or reduced their stakes in KVUE. BlackRock Inc. bought a new stake in Kenvue during the second quarter worth $2,882,279,000. Pentwater Capital Management LP purchased a new position in Kenvue during the 2nd quarter worth $977,094,000. Bank of America Corp DE bought a new stake in shares of Kenvue in the 2nd quarter worth $275,204,000. Legal & General Group Plc purchased a new stake in shares of Kenvue in the second quarter valued at about $253,393,000. Finally, Bank of New York Mellon Corp purchased a new stake in shares of Kenvue in the second quarter valued at about $192,080,000. Institutional investors and hedge funds own 97.64% of the company’s stock.
Kenvue Stock Performance
NYSE KVUE opened at $19.31 on Thursday. The business’s fifty day moving average is $18.51 and its 200-day moving average is $18.31. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.01 and a quick ratio of 0.71. The stock has a market capitalization of $37.09 billion, a price-to-earnings ratio of 21.94, a PEG ratio of 1.77 and a beta of 0.48. Kenvue Inc. has a one year low of $14.06 and a one year high of $20.13.
Kenvue (NYSE:KVUE – Get Free Report) last posted its quarterly earnings results on Friday, October 30th. The company reported $0.29 earnings per share for the quarter, meeting the consensus estimate of $0.29. The company had revenue of $3.89 billion during the quarter, compared to analyst estimates of $3.86 billion. Kenvue had a net margin of 10.76% and a return on equity of 21.22%. The firm’s revenue for the quarter was up 3.2% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.28 earnings per share. Equities research analysts predict that Kenvue Inc. will post 1.14 EPS for the current year.
Kenvue Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Friday, October 2nd. Stockholders of record on Monday, September 21st were given a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a dividend yield of 4.4%. The ex-dividend date of this dividend was Monday, September 21st. Kenvue’s dividend payout ratio is currently 95.45%.
Wall Street Analysts Forecast Growth
KVUE has been the topic of a number of recent analyst reports. Wall Street Zen lowered shares of Kenvue from a “buy” rating to a “hold” rating in a research report on Saturday, August 8th. HSBC dropped their target price on shares of Kenvue from $20.00 to $19.00 and set a “hold” rating on the stock in a research report on Monday, August 10th. UBS Group upped their target price on Kenvue from $19.00 to $20.00 and gave the company a “neutral” rating in a report on Monday, November 2nd. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Kenvue in a research report on Friday, September 11th. Ten analysts have rated the stock with a Hold rating. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $19.29.
View Our Latest Stock Analysis on KVUE
Kenvue Company Profile
Kenvue Inc. is a consumer health company that develops and sells products for everyday health and personal care. Its portfolio includes over-the-counter medicines, skin and hair care, oral care, wound care, and baby care products. Its well-known brands include Tylenol, Neutrogena, Aveeno, Listerine, Band-Aid, Johnson’s, and Zyrtec. Kenvue organizes its business around Self Care, Skin Health and Beauty, and Essential Health. The company became an independent business in 2023 after Johnson & Johnson completed the separation of its consumer health business.
Recommended Stories
- Five stocks we like better than Kenvue
- Amazon’s Zoox Just Joined Uber—Could That Change the Robotaxi Threat?
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
Want to see what other hedge funds are holding KVUE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kenvue Inc. (NYSE:KVUE – Free Report).
Receive News & Ratings for Kenvue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kenvue and related companies with MarketBeat.com's FREE daily email newsletter.
